Filed: 5/15/2026ACC: 0001618205-26-000002
📋 What this filing means
BIRCHVIEW CAPITAL, LP filed this quarterly 13F‑HR report disclosing 73 equity positions with a total reported market value of $175.66M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
73
Positions
$175.66M
Total AUM (reported)
10.92M
Total Shares
Allocation by class
COM$107.86M61.4%
COM NEW$45.54M25.9%
SHS$7.78M4.4%
SPONS ADR$4.82M2.7%
SPONSORED ADS$4.36M2.5%
ORD SHS$2.21M1.3%
CL A$1.77M1.0%
Portfolio Concentration
Top 3$55.61M31.7%
4–10$40.31M22.9%
11–25$41.98M23.9%
Rest$37.76M21.5%
Top 3 weight
31.7%
Top 10 weight
54.6%
Voting Authority Distribution
Total shares with voting rights: 10.92M
Sole
Full voting authority
10.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole73
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings73
Rows:
KLA CORPORATION
SOLEShares19.88K
TypeSH
Market value$29.28M
16.67%
Sole
19.88K
Shared
0.00
None
0.00
BRISTOL-MYERS SQUIBB CO
SOLEShares306.27K
TypeSH
Market value$18.58M
10.57%
Sole
306.27K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares1.47M
TypeSH
Market value$7.75M
4.41%
Sole
1.47M
Shared
0.00
None
0.00
LAM RESEARCH CORPORATION
SOLEShares36K
TypeSH
Market value$7.69M
4.38%
Sole
36K
Shared
0.00
None
0.00
STOKE THERAPEUTICS INC
SOLEShares210K
TypeSH
Market value$6.84M
3.89%
Sole
210K
Shared
0.00
None
0.00
OVINTIV INC
SOLEShares107.50K
TypeSH
Market value$6.38M
3.63%
Sole
107.50K
Shared
0.00
None
0.00
INTELLIA THERAPEUTICS INC
SOLEShares445.40K
TypeSH
Market value$5.71M
3.25%
Sole
445.40K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$4.82M
2.74%
Sole
100K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares625.98K
TypeSH
Market value$4.51M
2.57%
Sole
625.98K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares449.02K
TypeSH
Market value$4.36M
2.48%
Sole
449.02K
Shared
0.00
None
0.00
BIODESIX INC
SOLEShares286.80K
TypeSH
Market value$4.16M
2.37%
Sole
286.80K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares171K
TypeSH
Market value$3.81M
2.17%
Sole
171K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares35K
TypeSH
Market value$3.69M
2.10%
Sole
35K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares27.19K
TypeSH
Market value$3.58M
2.04%
Sole
27.19K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares219K
TypeSH
Market value$3.27M
1.86%
Sole
219K
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares409.39K
TypeSH
Market value$2.85M
1.62%
Sole
409.39K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares320K
TypeSH
Market value$2.71M
1.54%
Sole
320K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP
SOLEShares4.50K
TypeSH
Market value$2.67M
1.52%
Sole
4.50K
Shared
0.00
None
0.00
NEKTAR THERAPEUTICS
SOLEShares31K
TypeSH
Market value$2.23M
1.27%
Sole
31K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares70.09K
TypeSH
Market value$2.22M
1.27%
Sole
70.09K
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares202.33K
TypeSH
Market value$2.21M
1.26%
Sole
202.33K
Shared
0.00
None
0.00
EQT CORPORATION
SOLEShares34.62K
TypeSH
Market value$2.20M
1.25%
Sole
34.62K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares195K
TypeSH
Market value$2.17M
1.23%
Sole
195K
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares463.60K
TypeSH
Market value$2.15M
1.22%
Sole
463.60K
Shared
0.00
None
0.00
COMPASS PATHWAYS LTD
SOLEShares375K
TypeSH
Market value$2.07M
1.18%
Sole
375K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KLA CORPORATIONSOLE | COM NEW | 19.88K | SH | $29.28M 16.67% | 19.88K | 0.00 | 0.00 |
BRISTOL-MYERS SQUIBB COSOLE | COM | 306.27K | SH | $18.58M 10.57% | 306.27K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 1.47M | SH | $7.75M 4.41% | 1.47M | 0.00 | 0.00 |
LAM RESEARCH CORPORATIONSOLE | COM NEW | 36K | SH | $7.69M 4.38% | 36K | 0.00 | 0.00 |
STOKE THERAPEUTICS INCSOLE | COM | 210K | SH | $6.84M 3.89% | 210K | 0.00 | 0.00 |
OVINTIV INCSOLE | COM | 107.50K | SH | $6.38M 3.63% | 107.50K | 0.00 | 0.00 |
INTELLIA THERAPEUTICS INCSOLE | COM | 445.40K | SH | $5.71M 3.25% | 445.40K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONS ADR | 100K | SH | $4.82M 2.74% | 100K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 625.98K | SH | $4.51M 2.57% | 625.98K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 449.02K | SH | $4.36M 2.48% | 449.02K | 0.00 | 0.00 |
BIODESIX INCSOLE | COM | 286.80K | SH | $4.16M 2.37% | 286.80K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 171K | SH | $3.81M 2.17% | 171K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 35K | SH | $3.69M 2.10% | 35K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 27.19K | SH | $3.58M 2.04% | 27.19K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 219K | SH | $3.27M 1.86% | 219K | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 409.39K | SH | $2.85M 1.62% | 409.39K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 320K | SH | $2.71M 1.54% | 320K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORPSOLE | COM | 4.50K | SH | $2.67M 1.52% | 4.50K | 0.00 | 0.00 |
NEKTAR THERAPEUTICSSOLE | COM | 31K | SH | $2.23M 1.27% | 31K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 70.09K | SH | $2.22M 1.27% | 70.09K | 0.00 | 0.00 |
NOVOCURE LTDSOLE | ORD SHS | 202.33K | SH | $2.21M 1.26% | 202.33K | 0.00 | 0.00 |
EQT CORPORATIONSOLE | COM | 34.62K | SH | $2.20M 1.25% | 34.62K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 195K | SH | $2.17M 1.23% | 195K | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 463.60K | SH | $2.15M 1.22% | 463.60K | 0.00 | 0.00 |
COMPASS PATHWAYS LTDSOLE | SPONSORED ADS | 375K | SH | $2.07M 1.18% | 375K | 0.00 | 0.00 |
Page 1 of 3